Market Overview

Benzinga's M&A Chatter for Wednesday August 10, 2016

Share:

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday August 10, 2016:

 

Lam Research, KLA-Tencor Say Continue to Believe Deal is Pro-Competitive, Beneficial to Customers, Employees, Suppliers

The Comments:
Lam Research Corporation (NASDAQ: LRCX) and KLA-Tencor Corporation (NASDAQ: KLAC) announced Wednesday that they continue to work on receiving the necessary approvals from the DoJ and from competition authorities in Korea, Japan and China. The companies believe the transaction is pro-competitive and beneficial to their respective customers, employees and suppliers.

Lam Research closed Wednesday at $89.11 down 4.5%, while KLA-Tencor closed at $69.47, down more than 10%.

 

Judge to Start Aetna-Humana Merger Trial on December 5th

The Trial Date:
The U.S. District Court judge hearing the DoJ's case to block Aetna's (NYSE: AET) acquisition of Humana (NYSE: HUM) has selected December 5, 2016 as the trial date. The healthcare companies had requested an earlier date so that their deal could close within the planned time frame. The judge expects to rule in mid to late January 2017. U.S. District Court Judge Bates said during a hearing Wednesday that Aetna and Humana failed to show how a December trial would cause harm.

Aetna closed at $119.54 on Wednesday, flat. Human rose 1.45%, to close at $179.70.

 

Mesa Labs Reports Purchase of Cold Chain Manufacturing Capabilities

The Deal:
Mesa Laboratories, Inc. (NASDAQ: MLAB) announced Wednesday, the acquisition of certain assets and liabilities of Rapid Aid Corp by Mesa Canada. Terms were not disclosed.

Mesa Laboratories closed at $103.88 on Wednesday, up $0.11.

Posted-In: M&A News Rumors Movers

 

Related Articles (AET + HUM)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Watch These 5 Huge Put Purchases In Thursday Trade

Trade US Sales Numbers And Pricing Info On Friday